About SCCA Videos
What is SCCA?
SCCA Survival Rates
Bladder Cancer Videos
Dr. Jonathan Wright
Bone Marrow Transplant Doctor Videos
Dr. Frederick Appelbaum
Dr. Rainer Storb
Dr. Marc Stewart
Bone Marrow Transplant Treatment Videos
Haploidentical and Cord Blood Transplants
Partners in Hope: Bone Marrow Transplant
Brain Cancer Survivor Videos
Glioblastoma (Brain) Cancer Survivor Jairo Venegas
Breast Cancer Doctor Videos
Dr. Ben Anderson
Dr. Janice Kim
Dr. Constance Lehman
Dr. David Byrd
Dr. V.K. Gadi
Dr. Julie Gralow
Dr. Shannon Colohan
Breast Cancer Program Videos
NOW Clinic for Breast Cancer
The NOW Clinic provides care for newly diagnosed breast cancer patients. NOW stands for Newly Diagnosed Options for Women, but is also for men. The goal is to see patients within 48 hours, to offer reassurance, and help take away the unknown and fear. By the time patients first see their oncologist they'll know what type of breast cancer they have and what their pathology means.
Breast Cancer Care Team
In this video, Dr. VK Gadi describes the five core disciplines involved in managing breast cancer. In general, there are two doctors that you don't meet very often: they are the "what is it?" and "where is it?" doctors--your pathologist and radiologist. And then there are the "doing doctors." The two that go together, the surgeon and the radiation therapist are responsible for the breast and lymph nodes to make sure that whatever disease was once there is completely annihilated by either removing it (by surgery) or zapping it (by radiation). And finally there's the medical oncologist who comes in to eliminate whatever stray cancer cells that may have found their way to other parts of the body.
Breast Cancer Program
Breast Cancer Biology, Stages, and Types
Breast Cancer Treatment Videos
Dr. Julie Gralow at ASCO 2014
Dr. Gralow discusses new developments in the treatment of breast cancer at ASCO 2014.
T-DM1 for Breast Cancer
Breast Cancer Breakthroughs
Breast Cancer Surgery
Breast Cancer: ASCO 2012
Surgical Options for Breast Cancer
Surgical oncologist, Dr. Kristine Calhoun, talks about the surgical options for breast cancer patients. Generally, most patients will have surgery as part of their breast cancer treatment. Dr. Calhoun breaks down treatment options into two parts -- how to treat the breast (lumpectomy or mastectomy), and treatment of the lymph nodes. She also discusses the different types of lumpectomies and mastectomies and briefly touches on the rates of recurrence post-treatment. .
Wire Localization Procedure
When breast cancers cannot be felt, surgeons depend on wire localization to remove it. In this video, Dr. Kristine Calhoun walks through the process of wire localization. On the day of surgery, a radiologist, with the help of either an ultrasound or mammogram will locate the tumor and insert a guide wire and tape it in place. The wire allows the surgeon to triangulate the location of the tumor, determine where to make the incision, and where to remove tissue.
Sentinel Node Biopsy
A sentinel node is the first lymph node to which breast cancer is likely to spread. In this video, Dr. Kristine Calhoun, discusses when just the sentinel lymph nodes need to be removed and when it's necessary to remove more lymph nodes.
Biological and Targeted Therapies
Dr. VK Gadi is an oncologist who specializes in the treatment of breast cancer. In this video, Dr. Gadi explains how biologic or targeted therapies are designed to to go after specific vulnerabilities that are unique to the cancer. One therapy that Dr. Gadi is particularly excited about is the use of Herceptin for patients who have HER2-positive breast cancer. Herceptin is an monoclonal antibody which binds to the HER2 protein on the outside of a cancer cell. Once bound, it initiates a series of events that lead to the destruction of the cancer cell.
Clinical Studies for Breast Cancer
What is a clinical trial? Dr. VK Gadi addresses common misconceptions about clinical trials. He explains how cancer centers such as SCCA have access to not only phase III clinical trials, but phase I and phase II trials as well. Clinical trials provide access to novel drugs and treatments that are not commonly available. Dr. Gadi also explains how clinical trials are funded and how patients should not be worried about being stuck with the added burden of clinical trial expenses.
Chemotherapy for Breast Cancer
Dr. VK Gadi, a medical oncologist who specializes in caring for women with breast cancer, discusses chemotherapy. He explains that chemotherapy works by killing things are dividing rapidly, which is a characteristic of cancer cells. In most cases chemotherapy is effective at killing cancer cells, however there other cells in the body that divide rapidly, and that's where the toxicities of chemotherapy come in. Dr. Gadi tells how he helps his patients fight toxicities and avoid low white blood cell counts so they can live active, normal lives throughout their treatment.
Endocrine and Hormonal Therapies
Medical oncologists have three tools to fight breast cancer -- chemotherapy, endocrine therapy and hormone therapy. With hormone therapy, there are two strategies to get rid of hormone receptors that help cancer grow. Dr. VK Gadi describes these strategies including blocking the enzyme that turns pre-estrogen to active estrogen with a drug called Tamoxifen. The most serious side effects from treatment with Tamoxifen are blood clots, which occur in 2-3% of women taking the drug. Dr. Gadi discusses early warning indicators for these risks, and tells how he minimizes serious side effects with drugs such as aromatase inhibitors. He shares study results supporting his treatment strategy and points out the benefits to anti-estrogen therapy.
Breast Cancer Treatment
Dr. Larissa Korde discusses the options for treating breast cancer, including surgery, radiation, and systemic therapy. Surgically removing the tumor is one of the most important aspects of treating breast cancer and is almost always recommended. Radiation is used to target and kill any cancer cells that may remain after surgery. Radiation is always recommended after a lumpectomy, but often not recommended after a mastectomy. Following surgery, the local lymph nodes are evaluated--a procedure that's known as a sentinel lymph node biopsy--to see if the cancer has the potential to spread. Systemic therapies include chemotherapy, hormonal, and targeted therapies. Chemotherapy uses medicines to kill rapidly divining cells, but has toxicity and negative side effects. Hormonal therapies use pills to reduce hormone levels or block receptors, reducing the risk of recurrence by up to 50%. Targeted therapies are drugs specifically targeted to one abnormality, the most common of which is Herceptin.
The DIEP Flap Option for Breast Reconstruction
Dr. Shannon Colohan describes the DIEP flap option for breast reconstruction, which is a tissue-based reconstruction technique.
Breast Tissue Expanders for Breast Reconstruction
Dr. Shannon Colohan explains the process for getting breast tissue expanders before getting implants for women who opt for implant-based reconstruction after recovering from breast cancer.
Breast Cancer Radiation Therapy Videos
Radiation Treatment with Calypso
Radiation Treatment with Calypso
Radiation Treatment with Calypso
Radiation Treatment for Breast Cancer
Radiation therapy plays an important role in curing breast cancer. It is used to sterilize the breast and surrounding tissues by eradicating any residual cancer cells left behind after complete surgery or chemotherapy. Dr. Janice Kim discusses radiation treatment including common side effects and the rate of recurrences.
Radiation Treatment with Calypso
Dr. Janice Kim, Radiation Oncologist, discusses the Calypso Localization Program at Seattle Cancer Care Alliance. Calypso is a technique that allows radiation oncologists to more effectively deliver radiation treatment while reducing exposure to secondary organs, such as the heart.
Breast Cancer Screening Videos
Mammography and Breast Density
Dr. Janie Lee provides an overview of breast cancer screening recommendations, including considerations for women with dense breasts and new screening technologies.
Breast Cancer Screening with Dr. Larissa Korde
Breast Cancer Screening with Dr. Ben Anderson
Breast Cancer Screening with Dr. Constance Lehman
Breast Cancer Screening with Dr. Julie Gralow
BRCA Mutations and Breast Cancer
Dr. Larissa Korde discusses BRCA mutations and breast cancer. There is a lot of focus on understanding genetic predispositions to breast cancer. Some red flags to possible inherited mutations include early onset of breast cancer in women less than age 40, bilateral breast cancer occurring on both sides, and both breast and ovarian cancers occurring in the same family. The most common gene mutations for breast cancer are BRCA1 and BRCA2 mutations. While BRCA mutations are the cause of only 5-10% of breast cancers, women with these mutations have a risk as high as 50-85% of developing breast cancer, and 10-40% of developing ovarian cancer. Women found to have a BRCA mutation can undergo a more aggressive screening program to diagnose cancer at an earlier and more treatable stage, or can consider taking a more proactive approach including prophylactic mastectomy or oophorectomy to reduce their risk.
Breast Cancer Survivor Videos
Breast Cancer Survivor Diane Larkin
Breast Cancer Survivor Camille Mills
Breast Cancer Survivor Debra Jarvis
Breast Cancer Survivor Kelly Larkin-Holmes
Breast Cancer Survivor Keum Ja Bae
Cervical Cancer Videos
Cervical Cancer Screening with Dr. Linda Hipps
Cervical Cancer Screening Guidelines with Dr. Linda Hipps
Cervical Cancer Survivor Emily Wyse
Colon Cancer Doctor Videos
Dr. Alessandro Fichera
Dr. Edward Lin
Dr. Anthony Back
Dr. Andrew Coveler
Colon Cancer Treatment Videos
Dr. Edward Lin at ASCO 2014
Dr. Lin explains how the ADAPT trial may change the way we look at colorectal cancer treatment.
Colon Cancer Treatment with Dr. William Grady
Colon Cancer Treatment with Dr. Alessandro Fichera
Colon Cancer Treatment with Dr. David Byrd
Colon Cancer Screening Videos
Colon Cancer Screening with Dr. Alessandro Fichera
Colon Cancer Screening with Dr. William Grady
Colon Cancer Screening with Dr. Gabriela Chiorean
Colon Cancer Survivor Videos
Colon Cancer Survivor Mona Coyle
Colon Cancer Survivor Gaetano Boriello
Colon Cancer Survivor Anita Mitchell
Colon Cancer Survivor Barbara Crummins
Endometrial Cancer Videos
Endometrial Cancer with Dr. Barbara Goff
Gynecologic Cancer Videos
Dr. Barbara Goff
Dr. Heidi Gray
Dr. Benjamin Greer
Gynecologic Cancer Prevention with Dr. Barbara Goff
Head & Neck Cancer Videos
Dr. Eduardo Mendez
Early Symptoms of Throat Cancer
Drs. Eddie Mendez and Neil Futran, both head and neck cancer surgical oncologists, discuss the diagnosis and treatment of throat cancer. Although there has been a rise in tumors associated with Human Papillomavirus (HPV), there is also a better response rate for tumors that are in the back of the throat. Throat cancer can go undetected in early stages because there are less pain receptors in that area, so the first indicators that something is wrong include irritation that lasts more than a few weeks or difficulty swallowing. Because throat cancers affect critical functions such as speech, swallowing and appearance, treatment options are chosen to maximize these functions. Treatment options include surgery, radiation, and chemotherapy.
Oral Cancer Survivor Scott Morris
Scott Morris discusses being diagnosed and treated for oral cancer at SCCA. Scott was initially diagnosed and treated where he lives in Spokane, but was referred to Dr. Neil Futran at the University of Washington Medical Center when he wanted a second opinion on post-surgery recommendations. Scott was impressed with his personalized care from his first phone call with Dr. Futran. Scott was diagnosed at stage IV, and underwent a second tonsillectomy where they found more microscopic cancer. Doctors Futran and Mendez guided him through the challenging decision between his treatment options. Scott was treated with a caring, understanding and warmth by all the staff that he had not before experienced in health care, and has since encouraged five of his friends to get treatment at the University of Washington Medical Center and SCCA.
Dr. John Pagel at ASH 2013
Dr. John Pagel provides an update on the explosion of new targeted biological therapies for treating chronic lymphocytic leukemia (CLL), at the American Society of Hematology (ASH) 2013 Annual Meeting. These new treatments are offering new hope especially to patients with genetic abnormalities that made them more difficult to treat. These new drugs often work as well for high risk patients, possibly with just a shorter duration of remission than those at a lower risk. One example is GA101, a more potent and improved version of the commonly used Rituximab. The majority of CLL treatment is often a combination of therapies, but is evolving to less combinations involving chemotherapy, and more with various biological therapies. Dr. Pagel gave an example of a clinical trial of patients given Rituximab with either a placebo or Idelalisib (GS1101). The study was stopped early due to the overwhelming success, and all placebo patients were switched to Idelalisib.
Dr. Rainer Storb at ASH 2012
Leukemia Survivor Ron Robbecke
Lung Cancer Doctor Videos
Dr. Renato Martins
Dr. Michael Mulligan
Dr. Douglas Wood
Dr. Shilpen Patel
Dr. Farhood Farjah
Thoracic surgeon, Dr. Farhood Farjah, is inspired by his patients. He and his colleagues at Seattle Cancer Care Alliance take the time to get to know the people they work with and discuss how the treatment will impact their daily lives. Dr. Farjah's is board certified for general surgery, but his clinical focus is entirely on thoracic treatment. He specializes in minimally invasive surgery, which uses a series of small incisions rather than one large one. As a result, recovery time is reduced, patients get out of the hospital faster and experience less pain.
Lung Cancer Screening Videos
Dr. Renato Martins
Dr. David Madtes (long)
Dr. David Madtes (short)
Lung Cancer Surgery Videos
Minimally Invasive Surgery for Lung Cancer Treatment
Thoracic Surgery for Lung Cancer Treatment
Dr. Farhood Farjah describes the different types of thoracic surgery techniques for lung cancer treatment.
Lung Cancer Survival Rate Videos
Dr. Michael Mulligan on Survival Rates (long)
Dr. Michael Mulligan on Survival Rates (short)
Dr. Ajay Gopal
Dr. Oliver Press
CAR T-Cell Therapy
Dr. David Maloney discusses his excitement over CAR (chimeric antigen receptor) T-cell therapy, which uses patients' immune cells to fight back against cancer.
Dr. Stephen Smith at ASH 2013
Dr. Stephen Smith discusses advances in treatment for mantle cell lymphoma at ASH 2013. Dr. Smith feels this is a time of increased optimism for patients diagnosed with this rare and aggressive lymphoma that has historically been difficult to treat. Two new drugs were recently approved by the FDA. Revlimid (Lenalidomide) has been approved for patients having had two prior therapies, one including Bortezomib. Arutenib was given a breakthrough designation by the FDA based on its high clinical trial success, and is approved for patients having had one prior therapy. The challenge now is finding how to integrate these new therapies into current treatment regimens, and see results in real-world use that can differ slightly from clinical trials.
Dr. Ajay Gopal at ASH 2012
Dr. Oliver Press at ASH 2012
TIL Therapy for Advanced Melanoma
Dr. Sylvia Lee explains how tumor-infiltrating lymphocyte (TIL) therapy works to treat late-stage melanoma.
Multiple Myeloma Treatment Videos
Dr. Edward Libby at ASH 2013
Dr. Edward Libby provides an update on multiple myeloma treatment at ASH 2013. Dr. Libby is most excited about the research that's going into monoclonal antibodies for treatment of multiple myeloma. Monoclonal antibodies are relatively non-toxic, but have added to the quality of response in treatment of other diseases such as lymphoma. New trials are being conducted with Daratumumab in combination with Revlimid and Dexamethasone, with remarkable results for patients with relapsed and refractory multiple myeloma. Our understanding of smoldering myeloma is rapidly increasing, and positive results have been seen from beginning treatment at this earlier stage. However, Dr. Libby cautions that there is still much to learn and treatment of smoldering myeloma is not ready for the general world of oncology.
Dr. Damian Green at ASH 2013
Dr. Damian Green discusses the role of transplant in treating myeloma. Autologous stem cell transplant has been an available treatment for a number of years, and while not a lot has changed in transplant research, studies continue to show that it remains a vital part of treatment. New research is being conducted into the use of pretargeted radio immunotherapy as conditioning for transplant, which has been successful with lymphoma and leukemia. The pretargeting allows for an increased dose of radiation without added exposure.
ASH 2012 Multiple Myeloma Update with Dr. William Bensinger
In this interview from the 2012 American Society of Hematology (ASH) Annual Meeting, Dr. William Bensinger discusses the drug combination of Carfilzomib, Pomalidomide, and Dexamethasone. He explains the history and use of these drugs and how they were used in a phase one trial. The study gives patients less toxic therapy, a combination of more powerful medicines, and new hope. Learn more about this combination therapy for multiple myeloma.
Therapies for Myeloma Patients After Relapse with Dr. William Bensinger
Dr. William Bensinger discusses therapies to treat multiple myeloma after relapse with Andrew Schorr from Patient Power at the American Society of Hematology (ASH) annual meeting in 2012. Dr. Bensinger talks about the controversial role of allogeneic transplants to treat myeloma patients. He also discusses drugs, such as lenalidomide, that have shown promising results for relapse patients.
Amifostine for Multiple Myeloma with Dr. William Bensinger
Dr. William Bensinger shares the results of a clinical study that was presented at the 54th ASH Annual Meeting and Exposition. For some time, Dr. Bensinger has been interested in the use of amifostine, a drug which has been around for over 35 years and has been used to help protect patients from the toxicity of various treatments. Dr. Bensinger wanted to find out if amifostine could help protect patients from the toxicity of higher-dose melphalan treatments. The study found that who took amfostine were able to tolerate the higher doses of melphalan and also experience a higher response rate than those who took just the standard dose of melphalan.
Multiple Myeloma Treatment and Research
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger of Seattle Cancer Care Alliance, and Noopur Raje of Massachusetts General Hospital discuss treatment and research for multiple myeloma with Andrew Schorr from Patient Power. Dr. Raje, who researches drugs that can help with the bone complications of myeloma, states that they are able to decrease the risk of fractures by about 50% with bisphosphonates. She also discusses a clinical trial which uses osteoblasts to promote bone healing. In the more than 20 years that Dr. Bensinger has studied myeloma, he has never been more hopeful about his ability to fight the disease. Proteasome inhibitors such as bortezomib have dramatically changed the landscape. Remissions have lasted longer and patients have lived longer as a result of these drugs. Learn more about advancements in treatment of myeloma.
Understanding a Multiple Myeloma Diagnosis
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Dr. Noopur Raje discuss understanding the diagnosis of multiple myeloma with Andrew Schorr from Patient Power. Dr. Bensinger explains MGUS (monoclonal gammopathy of undetermined significance) and tells about the risk of progression to active myeloma, which is about 1% a year. He also discusses smoldering multiple myeloma, or asymptomatic myeloma. People with this form of the disease have a higher percentage of plasma cells in their blood and bone marrow, and a higher level of M protein in their blood, but they do not have bone disease, kidney disease and are not anemic. Learn more about their risk of progression to active myeloma.
Multiple Myeloma Testing and Personalized Treatment
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Dr. Noopur Raje discuss testing for the treatment of myeloma with Andrew Schorr from Patient Power. With the heterogeneity of the disease, adjusting the drug schedule and combination for the individual patient is the key to treatment efficacy and the control of side effects. Dr. Raje describes the panel of tests used to determine the appropriate individualized treatment regimen.
Stem Cell Transplant for Multiple Myeloma
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger of Seattle Cancer Care Alliance, discusses the treatment of myeloma with stem cell transplant. He describes an autologous transplant, where high doses of drugs such as melphalan to eradicate the myeloma, and outlines the side effects. Dr. Bensinger tells about clinical trials which are trying to determine if transplants as part of the initial therapy or later in the course of disease treatment is more effective.
Limiting Myeloma Treatment Side Effects
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Noopur Raje discuss ways to limit the side effects of treatment for myeloma with Andrew Schorr from Patient Power. Dr. Raje states that the goal is not just to live longer, but to live longer well. Because every patient experiences different side effects from the treatment of the disease, Dr. Raje says the key is communication with your medical team, including nurses. Listen for more tips on managing side effects of myeloma treatment.
Using Kyphoplasty to Help Relieve Myeloma Back Pain
Is the jury still out on the use of kyphoplasty to treat myeloma back pain? In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger describes the kyphoplasty procedure and how it stabilizes the vertebra to deliver pain relief. In this video he takes a question from a who was told that kyphoplasty should not be used in the lower back. Dr. Bensinger explains that is effective in the lower back, and tells what type of doctors typically perform the procedure.
Treating Multiple Myeloma with Bisphosphonates
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. Noopur Raje discusses treating myeloma with bisphosphonates with Andrew Schorr from Patient Power. Dr. Noopur Raje advocates the use of bisphosphonates in treating symptomatic myeloma, and explains how they work on the accessory cells which surround myeloma cells. She discusses the side effects related to the toxicities of bisphosphonates such as osteonecrosis of the jaw (ONJ). Current guidelines suggest bisphosphonates treatment for up to two years. Dr. Raje will be releasing data from a recent study supporting reducing the frequency of bisphosphonates treatments to every three months.
Treating Multiple Myeloma with Immunotherapy
Is there any research about treating myeloma with immunotherapy? In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger of SCCA discusses the eradication of chronic lymphocytic leukemia with adoptive T cell therapy. The effects of this treatment against multiple myeloma are currently being studied. Dr. Noopur Raje describes how adoptive t-cell therapy increases T cells and NK (natural killer) cells over time, which fight tumor cells. It ""wakes up"" your immune system and teaches it to fight against myeloma.
Multiple Myeloma Survivor Videos
Multiple Myeloma Patient Jamie Parsons
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, multiple myeloma patient Jamie Parsons and his wife Mary Beth Parsons discuss his diagnosis and participation in a clinical trial. They share their reaction to the diagnosis and describe how a support emerges from others who have dealt with myeloma. Mr. Parsons feels blessed to be a part of the first phase of a 16-month clinical trial. He did not experience side effects, and after more than 3 years, he is pleased with results of his monthly tests. He and Mary Beth are full of hope feel that myeloma is a disease to be managed rather than succumbed to.
Multiple Myeloma Patient Panel
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, multiple myeloma patients discuss their diagnosis, treatment, and living well with the disease. Moderator Andrew Schorr asks panelists about the process of dealing with the emotional impact of the diagnosis and communicating with loved ones and doctors. Panelists provide recommendations, such as assembling a team of doctors beyond your oncologist, to find additional support. They share their perspectives on participating in clinical trials.
Myelodysplastic Syndrome (MDS) Videos
Transplant for MDS Patients
MDS and Anemia
Ovarian Cancer Videos
Ovarian Cancer Biology and Facts
Dr. Heidi Gray describes ovarian cancer biology and facts. Ovarian cancer is the 2nd most common gynecologic cancer in the United States, affecting 22,000 - 25,000 women annually. It is less common than other forms of cancer such as breast cancer, but is difficult to treat as it is often diagnosed at a later stage where it has spread outside the ovary. There are not a lot of known risk factors, but approximately 15-20% of ovarian cancer cases are caused by a genetic mutation passed down in families. All women diagnosed with ovarian cancer should undergo genetic counseling and testing for the two most common genetic mutations, BRCA1 and BRCA2 mutations.
Ovarian Cancer Symptoms and Risk Factors
Dr. Heidi Gray describes ovarian cancer symptoms and risk factors. Ovarian cancer is the 2nd most common gynecologic cancer in the United States. Unfortunately the symptoms are nonspecific, such as bloating, mild abdominal pain, or changes with bladder, which are often attributed to other factors before discovering they may have ovarian cancer. As a result most ovarian cancers are diagnosed at a later stage. There is also not a successful screening strategy as few risk factors are known. The most common risk factor is genetics, which causes only 15-20% of ovarian cancer cases. All women diagnosed with ovarian cancer should undergo genetic counseling and testing for known genetic mutations, as they can have a higher risk for other disease such as breast cancer, and to alter family members to be screened.
Ovarian Cancer Treatment
Ovarian Cancer Treatment with Dr. Barbara Goff
Clinical Trials for Ovarian Cancer
Dr. Heidi Gray discusses participation in clinical trials for ovarian cancer. Ovarian cancer patients at Seattle Cancer Care Alliance are initially screened for eligibility to participate in a clinical trial. Trials range from Phase I trials that look at specific novel agents not available for use in oncology, to Phase III trials which are large national trials comparing a standard treatment to a treatment with additional therapy. Patients are matched to trials that are the right fit for them. It is also important that they have a sense of being part of the greater good, as results are often not known for 3-5 years and participating in trials often involve more intense therapy, monitoring, and more frequent visits.
Ovarian Cancer Survivor Jane Van Voorst
Pancreatic Cancer Doctors Videos
Dr. Sunil Hingorani
Dr. Venu Pillarisetty
Dr. James Park
Pancreatic Cancer Treatments Videos
Dr. Andrew Coveler at ASCO 2014
Dr. Coveler discusses the results of a Phase II trial focusing on multi-agent chemotherapy with radiation pre- and post-surgery for pancreatic cancer treatment.
Dr. Gabriela Chiorean Reports from ASCO 2013
Dr. Gabriela Chiorean, a GI medical oncologist, talks with Patient Power about two new therapies for pancreatic cancer patients. The first, a new combination therapy, abraxane plus gemcitabine, is now considered the gold standard for treating patients with metastatic pancreatic cancer. The second is a promising vaccine for pancreatic cancer, called HyperAcute Pancreas, that is aimed at early stage pancreatic cancer patients.
Dr. Sunil Hingorani Reports from ASCO 2013
Dr. Sunil Hingorani, a leader in pancreatic cancer research, explains the unique challenges in treating the disease. He shares the results of a Phase I trial that used PEGPH20 in combination with chemotherapy for patients with pancreas cancer. Dr. Hingorani described the trial as a new way to understand why the tumor is resistant to therapy and was encouraged by the initial results.
Surgery for Pancreatic Cancer
Patient Support Videos
Dr. Jesse Fann
Shine Retail Store with Dr. Julie Gralow (Long)
Dr. Julie Gralow of Seattle Cancer Care Alliance explains what's unique about Shine retail store. Located on the ground floor of SCCA House, it was designed with a focus on helping patients and loved ones get through cancer. The store offers compression garments, mastectomy bras, sexuality aids and other items in a very private, safe area, where patients can feel comfortable browsing and asking questions. Learn more about the shine store.
Shine Retail Store with Dr. Julie Gralow (Short)
Patient Support Services
Getting good cancer treatment is not just about getting the right drug. It is about patient support services, including pastoral care, social work, child life, nutritionists and even classes such as yoga and knitting. Listen to doctors and staff at Seattle Cancer Care Alliance tell about the services available to patients and their families to improve their treatment experience. It's the little things that make the difference when providing better care.
Pediatric Cancer Videos
Dr. Julie Park
Bone Marrow Transplant for Children
Leukemia Survivor Danel Lawrence
Prostate Cancer Doctor Videos
Dr. Bruce Dalkin
Dr. Celestia Higano
Dr. Robert Bruce Montgomery
Dr. Jonathan Wright
Prostate Cancer PSA Videos
PSA Screening (1)
PSA Screening (2)
A Place for the PSA Test
Prostate Cancer Treatment Videos
Prostate Cancer Treatment at SCCA
Prostate Cancer Survivor Videos
Prostate Cancer Survivor Rob Wilkinson
Rob Wilkinson considered himself healthy until he was diagnosed with prostate cancer, which registered a Gleason score of 9 out of 10. He shares how he found ""extraordinary care"" through the Seattle Cancer Care Alliance and the prostate cancer was contained. With a bright future ahead, Rob says having battled the disease has made him a better person. He has since recommended Seattle Cancer Care Alliance to a family member who also had his prostate removed.
Sarcoma Program at SCCA
Drs. Robin Jones and Darin Davidson discuss the sarcoma program at Seattle Cancer Care Alliance. Dr. Davidson explains that sarcoma affect connective tissue such as bone, muscle, fat, blood vessels and nerves. Dr. Jones says that there are about 70 known sub-types of sarcoma with their own clinical behavior, biology and response to systemic treatment. He explains how a team of doctors at SCCA review the pathology and radiology of each patient to formulate individualized treatment plans.
Dr. Robin Jones at ASCO 2014
Dr. Jones discusses recent clinical studies and long-term disease-control outcomes for sarcoma.
Leiomyosarcoma Survivor Warren Bailey
Sarcoma Survivor Rebecca Greenway
Stomach Cancer Survivor Videos
Stomach Cancer Survivor Ritsuko Hamai
Testicular Cancer Survivor Videos
Testicular Cancer Survivor Scott Whitman
UW-OncoPlex at SCCA
University of Washington Onco-Plex introduces a more precise way of choosing the most effective treatment for cancer patients. Dr. Colin Pritchard explains how. He tells about finding what makes each cancer unique in order to target the cancer's "Achilles heel" with treatment.